 | |
| Clinical data | |
|---|---|
| Other names | Nealbarbital, Censedal |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.008.386 |
| Chemical and physical data | |
| Formula | C12H18N2O3 |
| Molar mass | 238.287 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Nealbarbital (Censedal) is abarbiturate derivative developed byAktiebolaget Pharmacia in the 1950s.[1] It hassedative andhypnotic effects, and was used for the treatment ofinsomnia.
